[Myalgic encephalomyelitis : etiopathogenesis, diagnosis and treatment].

Rev Med Suisse

Département de pharmacologie, toxicologie et pharmacologie clinique, Université de médecine et pharmacie Iuliu Hațieganu Cluj-Napoca Victor Babes, No 8, 400012 Cluj-Napoca, Roumanie.

Published: July 2024

Myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS), is a neurological disorder involving multiple pathophysiological mechanisms and etiologies. Symptoms include asthenia, myalgia, post-exertional malaise and neurocognitive disorders. While the numerous patient complaints pose a diagnostic challenge, the advent of new technologies paves the way for innovative methods to reveal ME. The heterogeneity of the disease's mechanisms complicates the search for effective treatments but also offers the prospect of numerous beneficial molecules. Combining treatments targeting mitochondrial dysfunction, oxidative stress, inflammation and immunological disorders appears to be the current optimal therapeutic approach.

Download full-text PDF

Source
http://dx.doi.org/10.53738/REVMED.2024.20.882.1371DOI Listing

Publication Analysis

Top Keywords

[myalgic encephalomyelitis
4
encephalomyelitis etiopathogenesis
4
etiopathogenesis diagnosis
4
diagnosis treatment]
4
treatment] myalgic
4
myalgic encephalomyelitis
4
encephalomyelitis chronic
4
chronic fatigue
4
fatigue syndrome
4
syndrome cfs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!